Corporate News     10-Mar-23
Natco Pharma launches additional strengths for lenalidomide capsules in U.S.
Natco Pharma announced the launch of additional strengths for the generic version of Revlimid® (lenalidomide capsules), in 2.5 mg, and 20 mg strengths, in the United States, through its marketing partner Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries.

With this launch the companies made available all the strengths of lenalidomide in the US market. Lenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma

Previous News
  Natco Pharma standalone net profit rises 855.44% in the September 2023 quarter
 ( Results - Announcements 14-Nov-23   15:41 )
  Natco Pharma
 ( Results - Analysis 15-Feb-24   10:36 )
  Natco Pharma
 ( Results - Analysis 13-Aug-24   14:40 )
  Natco Pharma Ltd spurts 0.16%, rises for fifth straight session
 ( Hot Pursuit - 19-Dec-23   13:00 )
  Natco Pharma announces demise of director
 ( Corporate News - 31-Jul-24   11:56 )
  Natco Pharma to hold board meeting
 ( Corporate News - 09-May-24   16:50 )
  Natco Pharma consolidated net profit rises 549.65% in the September 2023 quarter
 ( Results - Announcements 14-Nov-23   17:36 )
  Natco Pharma Ltd spurts 2.09%, up for fifth straight session
 ( Hot Pursuit - 03-Apr-23   13:00 )
  Natco Pharma to table results
 ( Corporate News - 01-Feb-23   16:51 )
  Board of Natco Pharma recommends Third Interim Dividend
 ( Corporate News - 10-Feb-23   10:10 )
  Natco Pharma consolidated net profit declines 38.93% in the June 2021 quarter
 ( Results - Announcements 12-Aug-21   15:58 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top